GHRP-6 No Label

Active substance: GHRP-6

Pack: 5 mg x 1 vial

What is GHRP-6?
GHRP-6 (Growth Hormone-Releasing Peptide-6) is a synthetic hexapeptide and one of the first members of the Growth Hormone Releasing Peptide class. It is a potent ghrelin receptor (GHS-R1a) agonist designed to stimulate the endogenous secretion of growth hormone (GH). This product is supplied as a high-purity, lyophilized powder for controlled scientific research.

What does it do?
GHRP-6 primarily works by mimicking the natural hormone ghrelin. It binds to the ghrelin receptor in the pituitary gland and hypothalamus, triggering a robust, dose-dependent release of growth hormone. Unlike some secretagogues, GHRP-6 also stimulates the release of other hormones, including a slight increase in cortisol and prolactin, and has a pronounced effect on stimulating hunger.

How is it used?
This compound is provided for in-vitro (laboratory) research applications only. It is not for human or animal consumption. For experimental use, it must be reconstituted with an appropriate sterile solvent, such as bacteriostatic water. All subsequent handling, dosing, and administration must be performed according to specific, pre-defined research protocols in a qualified laboratory setting, adhering to all biosafety and chemical hygiene standards.

Potential Benefits (in a research context):

• Potent GH Stimulation: Serves as a powerful tool for studying the effects and pathways of growth hormone secretion in experimental models.

• Appetite Stimulation Research: Its strong orexigenic (appetite-stimulating) effect makes it valuable for studies on hunger regulation, cachexia, and metabolic disorders.

• Anabolic & Recovery Studies: Useful in research focused on muscle growth, tissue repair, wound healing, and the anti-catabolic effects of GH.

• Cardioprotective & Gastrointestinal Research: The ghrelin pathway is implicated in cardiac protection and gut motility, areas where GHRP-6 can be a relevant research tool.

• Comparative Studies: Allows for comparison with newer, more selective GHRPs (like Ipamorelin) to understand side effect profiles.

Possible Side Effects (research observations):
Based on scientific literature, administration of GHRP-6 in research models is associated with several notable effects:

• Strong Hunger Pangs: A significant and rapid increase in appetite is a hallmark response.

• Flushing and Tingling: Transient redness of the skin, warmth (especially in the face), and tingling sensations.

• Mild Water Retention: Can cause temporary fluid retention due to increased GH.

• Prolactin & Cortisol Elevation: May cause a slight, temporary rise in these hormones.

• Local Reactions: Potential for redness, itching, or discomfort at the site of injection in subcutaneous models.

• Drowsiness or Lethargy: Reported in some cases following administration.